";s:4:"text";s:5165:" [0027] The stable pharmaceutical dosage form may include an effective amount of each of entacapone, carbidopa, and levodopa as known to a person of skill in the art.
A stereoselective synthesis of l-carbidopa in seven steps and 50% overall yield from commercial compounds is described. However, the pharmaceutical dosage form described herein, which may be prepared by wet granulation and which may include microcrystalline cellulose, show acceptable stability. However, other granulation solutions containing different solvents or different binders may be used to prepare the stable pharmaceutical dosage form. -tetrasubstituted α-amino acid derivatives
The stable pharmaceutical dosage form of claim 22, wherein: said stable dosage form comprises 50 mg carbidopa, 200 mg levodopa, and 200 mg entacapone; and Formulation containing carbidopa, levodopa, and entacapone 26. CPEAK is the maximum plasma concentration of the drug and TPEAK is the time until the maximum plasma concentration is reached. All rights reserved
) complex. Table 3 [0048] Although the various embodiments have been described in detail with particular reference to certain aspects thereof, it should be understood that the stable pharmaceutical dosage form is capable of other embodiments and its details are capable of modifications in various obvious respects. The starch used in the stable pharmaceutical dosage form may be pregelatinized starch, corn starch, or a mixture thereof. The mixture may then be granulated with a granulating Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article.
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. 9.
) complex. Parkinson's disease is related to the depletion of dopamine. NH-type of chiral Ni(ii) complexes of glycine Schiff base: design, structural evaluation, reactivity and synthetic applications. Used alone, carbidopa has no effect on Parkinson’s symptoms. In one embodiment, the stable pharmaceutical dosage form may include about 25-400 mg of entacapone, preferably about 25-300 mg, and more preferably about 50-200 mg.
[0023] In one embodiment of the stable pharmaceutical dosage form, starch is mixed with the carbidopa, levodopa, and entacapone prior to granulation with the granulation solution. According to the specification, microcrystalline cellulose destabilizes carbidopa/levodopa/entacapone compositions that contain all three compounds when the formulation is stored for a long term. Any pharmaceutically acceptable form of microcrystalline cellulose may be used in the stable pharmaceutical dosage form.
Mo Wang, Muxing Zhou, Lu Zhang, Zhenfeng Zhang, Wanbin Zhang. N
The stable pharmaceutical dosage form of claim 22, further comprising an excipient selected from the group consisting of a starch, crospovidone, croscarmellose sodium, magnesium stearate, and a combination thereof. pharmaceutical dosage form meets at least one of the following conditions: i. the concentration of methyl-Dopa (L-tyrosine, 3-hydroxy-a- methyl-, sesquihydrate) is less than or equal to about 0.22%, by weight, at the time of manufacture; less than or equal to about 0.23%, by weight, after 8 weeks of storage at 40° C and 75% relative humidity; or less than or equal to about 0.24%, by weight, after 12 weeks of storage at 40° C and 75% relative humidity; ii. Doyoung Kim, Min Woo Ha, Suckchang Hong, Cheonhyoung Park, Byungsoo Kim, Jewon Yang, and Hyeung-geun Park .
Enantioselective α-Amination of Acyclic 1,3-Dicarbonyls Catalyzed by N-Heterocyclic Carbene. Asymmetric Enamine Catalysis with β-Ketoesters by Chiral Primary Amine: Divergent Stereocontrol Modes. Xiao Xiao, Lili Lin, Xiangjin Lian, Xiaohua Liu, Xiaoming Feng.
Find more information onGeneral experimental details for the preparation of β-ketoesters and Electronic Supporting Information files are available without a subscription to ACS Web Editions.
-{2-[
Enantioselective Synthesis of Chiral α-Azido and α-Aryloxy Quaternary Stereogenic Centers via the Phase-Transfer-Catalyzed α-Alkylation of α-Bromomalonates, Followed by SN2 Substitution. (H)-Ad Ni
Carbidopa, classified as a non-competitive decarboxylase inhibitor, is used in combination with the chemically related levodopa for the treatment of Parkinson’s disease or Parkinson-like symptoms (e.g. The process of claim 2, wherein the starch is selected from the group consisting of pregelatinized starch, corn starch, and a mixture thereof. Numient contains Levodopa-Carbidopa which are to be released in a modified release fashion during passage through the gastrointestinal tract. Impurity levels were measured by HPLC, however, impurities can be measured by any other standard measurement technique known to a N
Custom Synthesis; Analytical Services; About Us.